Press & news

FluoGuide develops surgical solutions that are expected to reduce suffering for the patient and increase the likelihood of cure as well as reducing costs for the health care system.

New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

New exchange: Nasdaq First North



Calendar &
upcoming reports


18- 19 January 2022

SEB Nordic Healthcare Seminar


30 March 2022

Year-end report 2021 and Annual report 2021


18 May 2022

Annual General Meeting


31 May 2022

Q1 report 2022


25 August 2022

Q2 report 2022


24 November 2022

Q3 report 2022



Show all posts